| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
C Martin Harris is Director at HSTM, with reported holdings spanning 4 companies. From March 2015 to May 2026, the filings on record show 0 open-market purchases and 12 sales. C Martin Harris's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10.4M at current prices.
Our model assigns C Martin Harris a below-average insider score of 39/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -4.5%.
C Martin Harris's largest disclosed position is in TMO as Director, worth about $6.7M. The TMO filings lean toward selling, a net 1,762 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2016 | TMO Thermo Fisher Scientific Inc. | Director | Sell | 390 | $157.33 | $61,358.70 | -7.7% | |
| Nov 3, 2015 | TMO Thermo Fisher Scientific Inc. | Director | Sell | 531 | $134.35 | $71,339.85 | -11.6% |